Figure 9
From: Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
Effect of a single intranasal administration of OG (5 mg/kg) on brain GLP-1 level in rats. Data are presented as means ± S.E.M. (n = 6). ***p < 0.001 compared to control group (Student’s t-test).
